Table 2.

Predicted serotype-specific vaccine effectiveness for the PCV7 serotypes in PCV13.

Serotype	Vaccine effectiveness Median (95% CI)
	United Kingdom	Australia	Germany
4	97% (61–100)	87% (59–97)	35% (2–97)
6B	86% (3–100)	70% (15–94)	94% (61–100)
9 V	75% (1–98)	60% (26–82)	80% (1–99)
14	97% (86–100)	86% (26–99)	97% (68–100)
18 C	99% (86–100)	80% (11–98)	74% (3–97)
19 F	91% (50–99)	12% (2–89)	56% (4–91)
23 F	87% (22–99)	67% (3–93)	88% (6–99)

CI confidence interval.